Fisetin Inhibits Osteoclastogenesis Through Prevention of RANKL-Induced ROS Production by Nrf2-Mediated Up-Regulation of Phase II Antioxidant Enzymes

Journal of Pharmacological Sciences - Japan
doi 10.1254/jphs.12243fp

Related search